Peptide injections for weight loss: what they actually are

You've seen the term 'peptide injections', here's where the confusion starts

Most people arrive at this question after seeing the phrase used interchangeably with 'weight loss jabs', 'GLP-1 injections' or specific brand names. The word 'peptide' just means a short chain of amino acids, and the gut hormones these medicines mimic (GLP-1, GIP) are peptides. So technically, yes, they are peptide-based. But the clinical term matters more than the marketing one. In the UK, the medicines with a licence for weight management are tirzepatide and semaglutide, both given as once-weekly injections via a pre-filled pen.

There is a common assumption that 'peptide injection' refers to a broad, loosely regulated category of compounds, the kind sold online as research chemicals. That's a separate and legally murky world. The medicines dispensed through UK pharmacies for weight management are fully authorised by the MHRA, manufactured to pharmaceutical standards, and require a prescription. The weight loss injections available in the UK are a defined, licensed set, not an open menu.

One misconception worth letting go: that these jabs are a quick cosmetic fix. The MHRA is clear that GLP-1 medicines are not assessed or licensed for rapid or purely cosmetic weight loss. The trials enrolled adults with obesity or weight-related health conditions, and the clinical benefit is measured over months, not weeks.

How these medicines actually work in the body

Tirzepatide activates both the GLP-1 and GIP receptors, the only dual-agonist weight-loss medicine currently licensed in the UK. Semaglutide targets the GLP-1 receptor alone. Both pathways do broadly similar things: they slow gastric emptying (food stays in the stomach longer, so you feel full sooner), reduce appetite signals in the brain, and influence insulin and glucagon secretion. The result is that people eat less, not through willpower, but through changes in biology.

The scale of weight reduction seen in trials was genuinely new. The STEP 1 trial, published in the New England Journal of Medicine, showed an average reduction of around 15% of body weight over 68 weeks with semaglutide 2.4mg. Tirzepatide's SURMOUNT-1 data showed average reductions of roughly 20–21% at the 15mg dose over 72 weeks. For context on how the two medicines compare head-to-head, see our page on finding the right injectable option.

Slowed gastric emptying also explains most of the common side effects: nausea, vomiting, diarrhoea, constipation, reflux, and fatigue. These tend to be most noticeable in the early weeks or after a dose increase, and typically settle as the body adjusts. For most people, starting on the lowest dose and titrating slowly (guided by a prescriber) keeps these manageable. The NHS tirzepatide medicines page covers the side-effect profile in detail.

Who these injections are licensed for, and what the clinical bar actually is

Licensing matters here. Both tirzepatide and semaglutide carry a UK licence for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition, things like high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A BMI above the threshold is not, on its own, a guarantee of suitability; a prescriber looks at the full picture, including your medical history and current medicines.

On the NHS, access to these medicines follows a phased rollout with additional criteria layered on top of the licensed thresholds. Many people don't meet the current NHS criteria, or find the waiting lists long. A private weight loss injection through a regulated UK pharmacy is the alternative route, subject to the same clinical assessment, just without the NHS queue. If you're unsure where you sit, the detail on what weight qualifies for weight loss injections is worth reading.

These medicines are not licensed for anyone under 18, and are not recommended during pregnancy, while breastfeeding, or when actively trying to conceive. Anyone with a history of certain conditions (including medullary thyroid carcinoma, pancreatitis, or some gastrointestinal disorders) will need careful prescriber review, and some will not be suitable candidates.

What a safe, legitimate prescription route looks like in practice

Because these are prescription-only medicines, the only legal route to them in the UK is a proper clinical assessment by a qualified prescriber. That means filling in a consultation, having your identity and current weight verified, and having a GPhC-registered prescriber review your answers. At nume, a real clinician reads every consultation (not software) and makes the prescribing decision the same day.

It's worth knowing how to check any online pharmacy you're considering. The GPhC register is public and searchable; a registered pharmacy's premises number should be easy to find on its website. Sellers offering these medicines without a clinical assessment, or at prices dramatically below the market, are a red flag. The MHRA has issued repeated warnings about counterfeit pens circulating online, and fake products have caused serious harm.

For a broader look at the medicines available, weight loss injections in the UK covers the licensed options in one place. If you'd like to understand the cost side of things before starting, our guide to weight loss injection pricing sets out what legitimate private treatment typically costs and why headline prices vary so much between providers.

If you think you might be a candidate, the first step is straightforward. Check your eligibility with a free consultation, reviewed the same day by one of our prescribers, with no commitment to proceed.